Evolution of the Average Target: Imerys

Evolution of the Target Price: Imerys

Changes in Analyst Recommendations: Imerys

c980e9d80fc29c5b6774971.Ni7b_il3hDNDFru__iSR_UiltFWYjVdRF6OAms9gtyA.VGuRjmQZvHh7JO2JhxDhpzLJ7QPuyGMjJdHB6Z1VwE0ORZLMYT-0eBty_g~ea9b2a87b5debcb3caa9b9f518a89f9a
08-03 Imerys: H1 2026: The recovery is thinner than reported EBITDA suggests Alphavalue
04-30 Imerys: Q1: FX and restructuring flush earnings Alphavalue
04-30 Schneider Electric, Capgemini, Societe Generale... stocks to watch today in Paris Zonebourse
04-01 Oddo BHF maintains Outperform rating on Imerys but trims price target Zonebourse
03-18 AlphaValue/Baader Europe Slashes EPS Estimates for Imerys Amid 'More Conservative' View MT
03-17 Imerys: EPS cut (2025: from € 1.87 to -4.01, 2026: from € 2.30 to 1.22) Alphavalue
02-23 Imerys: FY 2025: Imerys turns to cost cutting as recovery remains elusive Alphavalue
02-23 Oddo BHF Maintains Outperform Rating on Imerys Zonebourse
31/10/25 Imerys: Cautious Optimism: Imerys Lays the Groundwork for Recovery Alphavalue
21/08/25 AlphaValue/Baader Europe Cuts EPS Estimates for Imerys on Weaker-than-expected H1 Results MT
20/08/25 Imerys: AlphaValue confirms buy recommendation Zonebourse
20/08/25 Imerys: Target cut by -26.3% Alphavalue
07/08/25 Imerys: H1 2025: Imerys struggles amid broad slowdown Alphavalue
30/07/25 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
09/07/25 Imerys: Oddo BHF cuts target price Zonebourse
29/04/25 Imerys: Q1 '25: Decline and Uncertainty Alphavalue
21/02/25 Imerys: Margin growth despite uneven market conditions Alphavalue
21/01/25 Imerys: EPS cut (2024: -1.3%, 2025: -19.6%) Alphavalue
28/11/24 Imerys: Berenberg cuts target, maintains buy rating Zonebourse
31/10/24 Imerys: Sequential volume growth offers reassurance Alphavalue
03/10/24 Imerys: EPS cut (2024: -29.0%, 2025: -6.0%) Alphavalue
18/09/24 Imerys: up sharply after positive analysis Zonebourse
18/09/24 Imerys: a stock to own in 2025, according to Berenberg Zonebourse
11/09/24 Imerys: Target cut by -23.8% Alphavalue
01/08/24 Imerys: Gradual progress in operations amid a cautious outlook Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.51%
-15.93%
+0.2%
+46.09%
- - -
+37.6%
+36.2%
+51.26%
+45.07%
+23.92%
Average +26.55%
Weighted average by Cap. +7.87%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
22.40EUR
Average target price
25.65EUR
Spread / Average Target
+14.51%
High Price Target
30.00EUR
Spread / Highest target
+33.93%
Low Price Target
23.00EUR
Spread / Lowest Target
+2.68%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA